Celcuity, Inc. (CELC)

111.17 +3.79 (+3.53%) USD  |  NASDAQ  |  Feb 26, 11:01
More

Celcuity Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for CELC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Relay Therapeutics, Inc. Upgrade
Praxis Precision Medicines, Inc. Upgrade